Delhi High Court reinstates Injunction stopping sale of Zydus’ Sigrima
The decision, made in response to Roche's appeal on October 16, 2024, reversed an earlier order from October 9, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Roche
Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India:…
GlobalData reports the rise in HER2+ breast cancer cases, stressing the importance of cost-effective biosimilars as Zydus and…
Roche’s Vabysmo showcases stronghold across wAMD and DME spaces : GlobalData
The data showcases Vabysmo’s efficacy in wet age-related macular degeneration (wAMD) and diabetic macular edema (DME)
Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028:…
GlobalData’s patient-based forecast reveals that the BRAF inhibitor market for melanoma will reach a key milestone by 2028, with…
USFDA grants priority review to Roche’s glofitamab
If approved, glofitamab would be the first fixed-duration CD20xCD3 T-cell engaging bi-specific antibody approved to treat the most…
USFDA approves Roche’s lymphoma therapy
The drug, known chemically as mosunetuzumab, can be administered at a hospital’s outpatient centre, unlike some other follicular…
Roche appoints Thomas Schinecker as new Group CEO
The company will propose Severin Schwan as the new Chairman at the Annual General Meeting in 2023
Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Updated data from phase-III Polarix study continue to demonstrate a statistically significant reduction in the risk of disease…
Roche’s Alzheimer’s drug fails to meet goal in long awaited trial
The Swiss drugmaker conducted two identically designed studies, each with about 1,000 participants, who were examined and queried…
FDA accepts supplemental Biologics Licence Application for Roche’s Polivy combination
The acceptance has been given for people with previously untreated diffuse large B-cell lymphoma